Fulminant hepatic failure

Lancet

Volumn 349, Issue 9058, 1997, Pages 1081-1085

  Mas, A ^a   Rodes J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACICLOVIR; ACTIVATED CARBON; AMPHETAMINE DERIVATIVE; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTITHYROID AGENT; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; DOPAMINE; FLUMAZENIL; HALOTHANE; MANNITOL; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTACYCLIN; TUBERCULOSTATIC AGENT;

BACTERIAL INFECTION; BLEEDING; BLOOD DISEASE; BRAIN DISEASE; BRAIN EDEMA; CLINICAL FEATURE; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; HEPATITIS; HEPATITIS VIRUS; HERPES; HUMAN; HYPOGLYCEMIA; KIDNEY FAILURE; LIVER FAILURE; LIVER TRANSPLANTATION; MORTALITY; MUSHROOM POISONING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030991407     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)08054-3     Document Type: Review

References (35)

1. Trey C, Davidson LS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in liver diseases. New York: Grune and Stratton, 1970: 282-98.
2. Bernuau J, Reuff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986; 6: 97-106.
3. Gimson AES, O'Grady J, Ede RJ, et al. Late-onset hepatic failure: clinical, serological and histological features. Hepatology 1986; 6: 188-94.
4. Wright TL, Hsu H, Donegan E, et al. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med 1991; 115: 111-21.
5. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-32.
6. Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure. Lancet 1996; 347: 1552.
7. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 1992; 340: 384-87.
8. Muñoz SJ. Difficult management problems in fulminant hepatic failure. Semin Liver Dis 1993; 13: 395-413.
9. Caraceni P, van Thiel DH. Acute liver failure. Lancet 1995; 345: 163-69.
10. Bernuau J, Benhamou JP. Fulminant and subfulminant liver failure. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodés J, eds. Oxford textbook of clinical hepatology. Oxford: Oxford Medical Publications, 1991: 923-42.
11. Williams R, Gimson AES. Intensive liver care and management of acute liver failure. Dig Dis Sci 1991; 36: 820-26.
12. Ware AT, D'Agostino AN, Conises B. Cerebral edema: a major complication of massive hepatic necrosis. Gastroenterology 1971; 61: 877-84.
13. Wendon JA, Harrison PM, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 1994; 19: 1407-13.
14. Blei AT. Cerebral edema and intracranial hypertension in acute liver failure: distinct aspects of the same problem. Hepatology 1994; 13: 376-79.
15. Ferenci P. Brain dysfunction in fulminant hepatic failure. J Hepatol 1994; 21: 487-90.
16. Blei AT, Olafson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993; 341: 157-58.
17. Aggarwal S, Kramer D, Yonas H, et al. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology 1994; 19: 80-87.
18. O'Grady JG, Williams R. Acute liver failure. In: Gilmore IT, Shields R, eds. Gastrointestinal emergencies. Eastbourne: WB Saunders, 1992: 104-22.
19. Navasa M, Panés J, Terés J, Bruguera M, Rodés J. Insuficiencia hepätica aguda grave: análisis de 51 casos. Gastroenterol Hepatol 1986; 9: 221-27.
20. Gimson AES. Bacterial infections in acute liver failure. In: Rodés J, Arroyo V, eds. Therapy in liver diseases. Barcelona: Doyma, 1992; 407-11.
21. Salmerón JM, Titó L, Rimola A, et al. Selective intestinal decontamination in patients with acute liver failure. J Hepatol 1992; 14: 280-85.
22. Rolando N, Gimson A, Wade J, et al. Prospective controlled trial of selective parenteral and enteral antimicrobial regime in fulminant liver failure. Hepatology 1993; 17: 196-201.
23. Rolando N, Harvey F, Braham J, et al. Fungal infection: a common, unrecognized complication of acute liver failure. J Hepatol 1991; 12: 1-9.
24. Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1852-57.
25. Kondrup J, Almadal T, Vilstrup H, Tygstrup N. High volume plasma exchange in fulminant hepatic failure. Int J Art Organs 1992; 15: 669-76.
26. Sherlock S. Fulminant hepatic failure. Adv Intern Med 1993; 38: 245-67.
27. O'Grady JG, Alexander FJM, Hayllar KM, Williams R. Early indications of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
28. Bismuth H, Samuel D, Gugenheim J, et al. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 1987; 107: 337-41.
29. Bernuau J, Samuel D, Durand F, et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V (FV) below 50% of normal: a prospective study. Hepatology 1991; 14: 49 (abstr).
30. Castells A, Salmerón JM, Navasa M, et al. Liver transplantation for acute liver failure: analysis of applicability. Gastroenterology 1993; 105: 532-38.
31. de Knegt RJ, Schalm SW. Fulminant hepatic failure: to transplant or not to transplant. Neth J Med 1991; 38: 131-41.
32. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273-75.
33. Bernuau J, Benhamou JP. Classifying acute liver failure. Lancet 1993; 342: 252-53.
34. Lidofsky SD, Bass NM, Prager MC, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology 1992; 16: 1-7.
35. Chenard-Neu MP, Boudjema K, Bernuau J, et al. Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure. Hepatology 1996; 23: 1119-27.